Eli Lilly’s Obesity Drugs Drive Massive Revenue GrowthBy Press Room6 August 2026 In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and…